Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Messmore

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Circulation|December 31, 1997
Plasma thrombomodulin level as a predictor of hemorrhagic (and thrombotic) events in patients on long-term anticoagulant treatmentJ Fareed, H L Messmore
Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic use of low molecular weight heparinsH L Messmore, W H Wehrmacher
Comprehensive Therapy|June 1, 1990
Thromboembolic disease during pregnancy: problems with anticoagulant therapyW H Wehrmacher, H L Messmore
Seminars in Thrombosis and Hemostasis|October 1, 1983
Newer avenues in the monitoring of antithrombotic therapy: the role of automationJ M Walenga, J Fareed, H L Messmore
Clinical Chemistry|September 1, 1980
New perspectives in coagulation testingJ Fareed, H L Messmore, E W Bermes
Seminars in Thrombosis and Hemostasis|October 1, 1984
Molecular markers of platelet activationH L Messmore, J M Walenga, J Fareed
Postgraduate Medicine|May 15, 1991
Acute venous thrombosis. Therapeutic choices for superficial and deep veinsH L Messmore, M Bishop, W H Wehrmacher
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparinH L Messmore, R Kundur, W Wehrmacher, et al.
Journal of Thrombosis and Thrombolysis|January 13, 2001
Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, H L Messmore
Thrombosis Research|December 1, 1981
Laser nephelometric quantitation of antithrombin-III (AT-III) development of a new assayZ Parvez, J Fareed, H L Messmore, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Circulation|December 31, 1997
Plasma thrombomodulin level as a predictor of hemorrhagic (and thrombotic) events in patients on long-term anticoagulant treatmentJ Fareed, H L Messmore
Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic use of low molecular weight heparinsH L Messmore, W H Wehrmacher
Comprehensive Therapy|June 1, 1990
Thromboembolic disease during pregnancy: problems with anticoagulant therapyW H Wehrmacher, H L Messmore
Seminars in Thrombosis and Hemostasis|October 1, 1983
Newer avenues in the monitoring of antithrombotic therapy: the role of automationJ M Walenga, J Fareed, H L Messmore
Clinical Chemistry|September 1, 1980
New perspectives in coagulation testingJ Fareed, H L Messmore, E W Bermes
Seminars in Thrombosis and Hemostasis|October 1, 1984
Molecular markers of platelet activationH L Messmore, J M Walenga, J Fareed
Postgraduate Medicine|May 15, 1991
Acute venous thrombosis. Therapeutic choices for superficial and deep veinsH L Messmore, M Bishop, W H Wehrmacher
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparinH L Messmore, R Kundur, W Wehrmacher, et al.
Journal of Thrombosis and Thrombolysis|January 13, 2001
Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, H L Messmore
Thrombosis Research|December 1, 1981
Laser nephelometric quantitation of antithrombin-III (AT-III) development of a new assayZ Parvez, J Fareed, H L Messmore, et al.
Pageof 7